Crimean-Congo hemorrhagic fever virus in Central, Eastern, and South-eastern Asia

Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-Congo hemorrhagic fever virus (CCHFV), is endemic in Africa, Asia, and Europe, but CCHF epidemiology and epizootiology is only rudimentarily defined for most regions. Here we summarize what is known about CCHF in Central, Eastern, and South-e...

Full description

Saved in:
Bibliographic Details
Published inVirologica Sinica Vol. 38; no. 2; pp. 171 - 183
Main Authors Fereidouni, Mohammad, Apanaskevich, Dmitry A., Pecor, David B., Pshenichnaya, Natalia Yu, Abuova, Gulzhan N., Tishkova, Farida H., Bumburidi, Yekaterina, Zeng, Xiankun, Kuhn, Jens H., Keshtkar-Jahromi, Maryam
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2023
Wuhan Institute of Virology, Chinese Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-Congo hemorrhagic fever virus (CCHFV), is endemic in Africa, Asia, and Europe, but CCHF epidemiology and epizootiology is only rudimentarily defined for most regions. Here we summarize what is known about CCHF in Central, Eastern, and South-eastern Asia. Searching multiple international and country-specific databases using a One Health approach, we defined disease risk and burden through identification of CCHF cases, anti-CCHFV antibody prevalence, and CCHFV isolation from vector ticks. We identified 2313 CCHF cases that occurred in 1944–2021 in the three examined regions. Central Asian countries reported the majority of cases (2,026). In Eastern Asia, China was the only country that reported CCHF cases (287). In South-eastern Asia, no cases were reported. Next, we leveraged our previously established classification scheme to assign countries to five CCHF evidence levels. Six countries (China, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan) were assigned to level 1 or level 2 based on CCHF case reports and the maturity of the countries’ surveillance systems. Two countries (Mongolia and Myanmar) were assigned to level 3 due to evidence of CCHFV circulation in the absence of reported CCHF cases. Thirteen countries in Eastern and South-eastern Asia were categorized in levels 4 and 5 based on prevalence of CCHFV vector ticks. Collectively, this paper describes the past and present status of CCHF reporting to inform international and local public-health agencies to strengthen or establish CCHFV surveillance systems and address shortcomings. •CCHF is endemic in Africa, Asia, and Europe, but the disease's epidemiology and epizootiology is only rudimentarily defined.•We identified 2313 cases of CCHF that occurred from 1944 to 2021 in Central, Eastern, and South-eastern Asia.•We identified six countries with clear evidence of occasional or frequent outbreaks; two countries with likely circulation of CCHFV; and thirteen countries in which CCHFVs vector tick is present.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1995-820X
1674-0769
1995-820X
DOI:10.1016/j.virs.2023.01.001